The PRH/Hex repressor protein causes nuclear retention of Groucho/TLE co-repressors by Desjobert, C et al.
 
 
The PRH/Hex repressor protein causes nuclear
retention of Groucho/TLE co-repressors
Desjobert, C; Noy, Peter; Swingler, T; Williams, H; Gaston, Kevin; Jayaraman, Padma-Sheela
DOI:
10.1042/BJ20080872
Citation for published version (Harvard):
Desjobert, C, Noy, P, Swingler, T, Williams, H, Gaston, K & Jayaraman, P-S 2009, 'The PRH/Hex repressor
protein causes nuclear retention of Groucho/TLE co-repressors', Biochemical Journal, vol. 417, no. 1, pp. 121-.
https://doi.org/10.1042/BJ20080872
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Feb. 2019
 
 
 
The PRH/Hex repressor protein causes 
nuclear retention of Groucho/TLE 
corepressors. 
 
 
 
Cecile Desjobert2, Peter Noy1, Tracey Swingler,2 Hannah Williams2, Kevin Gaston2 
and Padma-Sheela Jayaraman1,2*  
 
 
 
 
 
1Division of Immunity and Infection, School of Medicine, University of Birmingham, 
Edgbaston, Birmingham, B152TT, U.K. and 2Department of Biochemistry, Medical 
School, University Walk, University of Bristol BS81TD, UK. 
 
Running title: Transcriptional co-repression by PRH and TLE 
 
 
 
 
 
 
 
 
*corresponding author 
Phone: (+44-121-414-6820) 
Fax: (+ 44-121-414-8817) 
E-mail: p.jayaraman@bham.ac.uk
Abbreviations: PRH, Proline-Rich Homeodomain; TLE, transducin-like Enhancer of 
split; TK, thymidine kinase;  
Biochemical Journal Immediate Publication. Published on 19 Aug 2008 as manuscript BJ20080872
TH
IS
 IS
 N
O
T 
TH
E 
VE
RS
IO
N 
O
F 
RE
CO
RD
 - 
se
e 
do
i:1
0.
10
42
/B
J2
00
80
87
2
Ac
ce
pte
d M
nu
sc
rip
t
Licenced copy. Copying is not permitted, except with prior permission and as allowed by law.
© 2008 The Authors Journal compilation © 2008 Biochemical Society
  Desjobert et al 
SYNOPSIS 
 
The Proline-Rich Homeodomain protein (PRH/Hex) is a transcription factor 
that functions as an important regulator of vertebrate development and many other 
processes in the adult including haematopoiesis. The Groucho/TLE family of co-
repressor proteins also regulate development and modulate the activity of many 
DNA-binding transcription factors during a range of diverse cellular processes 
including haematopoiesis. We have shown previously that PRH is a repressor of 
transcription in haematopoietic cells and that an Eh-1 motif present within the N-
terminal transcription repression domain of PRH mediates binding to Groucho/TLE 
proteins and enables co-repression. Here we demonstrate that PRH regulates the 
nuclear retention of TLE proteins during cellular fractionation. We show that 
transcriptional repression and the nuclear retention of TLE proteins requires PRH to 
bind to both TLE and DNA. In addition, we characterise a trans-dominant negative 
PRH protein that inhibits wild type PRH activity by sequestering TLE proteins to 
specific sub-nuclear domains. These results demonstrate that transcriptional 
repression by PRH is dependent on TLE availability and suggest that sub-nuclear 
localisation of TLE plays an important role in transcriptional repression by PRH. 
  
 
Key words: Transcriptional repression, nuclear retention, PRH, HEX, Groucho, TLE, 
co-repressor, haematopoiesis, trans-dominant negative. 
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INTRODUCTION 
 
Transcription factors that bind to DNA are important regulators of multiple 
processes in the cell and often act in conjunction with non-DNA binding co-
repressors and co-activators to bring about changes in gene expression. Generally the 
role of the co-regulatory proteins is to recruit chromatin remodelling enzymes or 
chromatin binding proteins in order to set up more open or closed chromatin 
configurations. Most co-activators and co-repressors are able to interact with a variety 
of DNA bound factors to regulate gene expression. The Proline-Rich Homeodomain 
protein (PRH/Hex) is a DNA binding transcription factor, that can regulate gene 
expression in  a number of tissues using multiple mechanisms,  (reviewed in Soufi 
and Jayaraman 2008 [1]). PRH forms oligomers in cells and can bind to DNA in the 
oligomeric state [2]. When bound to DNA, PRH generally functions as a repressor of 
transcription [3-6] and we have shown previously that PRH can recruit members of 
the Groucho/TLE family of co-repressor proteins [7]. However, in some contexts 
PRH functions as a DNA bound activator of transcription [8]. PRH can also regulate 
transcription without binding to DNA by regulating the activity of other DNA-
binding transcription factors [9-11]. In addition, PRH can regulate gene expression 
post-transcriptionally by regulating the transport of specific mRNAs from the nucleus 
to the cytoplasm [12].  
PRH regulates embryonic development in all vertebrates and is necessary for 
the development of embryonic forebrain, thyroid, lungs, liver and heart [13-15]. PRH  
also plays a role in the early development of vascular tissues and the formation of 
haematopoietic lineages [13;16-20]. In the adult, PRH is expressed in thyroid, liver 
and lungs [21] and may play a role in maintenance of differentiation of these tissues. 
Moreover this protein regulates haematopoiesis in the embryo and in the adult 
[13;22]. PRH is strongly expressed in pluripotent haematopoietic progenitors, in 
erythromyeloid and B-cell progenitors but not in T-cell lineages [20;23-25]. In 
general, the gradual down-regulation of PRH is associated with differentiation of 
most haematopoietic lineages [24;26]. PRH interacts with the growth control proteins 
PML and translation initiation factor eIF4E [27] and has been shown to regulate cell 
growth or differentiation in haematopoietic cells as well as in a number of different 
tissues [16;28;29]. Decreased PRH expression and loss of nuclear localisation of PRH 
is implicated in a number of human myeloid leukaemias [30;31]. In addition a 
chromosomal translocation resulting in a PRH fusion protein that can activate 
transcription and has trans-dominant negative activity over wild type PRH has been 
shown to be a causative agent in Acute Myeloid Leukaemia [32]. 
The PRH protein consists of three regions: a proline-rich N-terminal domain, 
a central homeodomain, and an acidic C-terminal domain. The proline-rich N-
terminal domain of PRH can make multiple protein-protein interactions and binds to 
several proteins including PML [27], eIF4E [12], proteosome subunit HC8 [33] and 
members of the Groucho/TLE [7] family of co-repressor proteins. PRH forms foci in 
haematopoietic cells and exists as oligomeric complexes in vivo and in vitro [2]. The 
N-terminal domain of PRH is required for oligomerisation and transcriptional 
repression and can influence the DNA binding activity of the PRH homeodomain 
[2;34]. As well as binding to DNA [6], the PRH homeodomain is important in PRH 
oligomerisation [2] and forms protein-protein interactions with other transcription 
factors [11]. The C-terminal domain of PRH is rich in acidic residues but appears to 
play no role in repression [6]. However, both the homeodomain and C-terminal 
domain are reported to play a role in transcription activation by PRH [35].  
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The TLE proteins are members of a family of transcription co-repressors that 
includes the archetypical Drosophila protein Groucho. Like PRH, Groucho/TLE 
family proteins are involved in many developmental decisions including: neuronal 
and epithelial cell differentiation, segmentation and sex determination and the 
differentiation of haematopoietic, osteoblast and pituitary cells [36-40]. Members of 
the Groucho/TLE family do not have DNA binding activity but are instead recruited 
to DNA by interactions with DNA binding proteins. Once recruited to a promoter, 
these proteins can bring about long range transcriptional repression by recruiting 
histone deacetylases [41-43] and by interacting directly with histones [44]. TLE 
proteins form tetramers and larger oligomeric complexes and oligomerisation is 
essential for co-repression [45;46]. The TLE proteins are phosphoproteins and are 
hyperphosphorylated during the cell cycle and during cell differentiation [45;47;48]. 
A subset of the DNA binding transcription factors that interact with Groucho/TLE 
proteins in the haematopoietic compartment, including Hes1, Runx-1 and Pax5, have 
been shown to play a role in regulating TLE phosphorylation and modulating its 
activity [49;50]. For example, Hes1- and Runx-1-dependent phosphorylation of 
nuclear TLE-1 by CK2 has been shown to increase its co-repressor activity and its 
association with chromatin [49]. In contrast, phosphorylation of TLE by 
homeodomain interacting protein kinase 2 (HIPK2) decreases its co-repression ability 
[51]. 
We have shown previously that endogenous PRH and TLE are present in both 
the cytoplasmic and the nuclear compartments of K562 cells [7]. We have also shown 
that a short sequence of amino acids in the PRH N-terminal domain, known as the 
Engrailed homology motif (Eh-1), mediates the binding of PRH to TLE proteins. 
Moreover we demonstrated that a direct interaction between TLE1 and PRH is 
required for co-repression of transcription [7]. In the present study we demonstrate 
that PRH brings about nuclear retention of endogenous TLE proteins in early myeloid 
progenitors (K562-blasts). Furthermore we show that a mutated form of PRH that is 
defective in DNA binding can function as a trans-dominant negative of wild-type 
PRH by sequestering TLE proteins.  
 4
Biochemical Journal Immediate Publication. Published on 19 Aug 2008 as manuscript BJ20080872
TH
IS
 IS
 N
O
T 
TH
E 
VE
RS
IO
N 
O
F 
RE
CO
RD
 - 
se
e 
do
i:1
0.
10
42
/B
J2
00
80
87
2
Ac
ce
pte
d M
an
us
cri
pt
Licenced copy. Copying is not permitted, except with prior permission and as allowed by law.
© 2008 The Authors Journal compilation © 2008 Biochemical Society
  Desjobert et al 
EXPERIMENTAL  
 
Mammalian Expression and reporter plasmids  
The mammalian expression plasmid pMUG1-Myc-PRH expresses Myc-
tagged human PRH (amino acids 7-270). pMUG1-Myc-PRH and pMUG1-Myc-
PRHF32E have been described previously [7]. A QuikChange kit (Stratagene) was 
used according to the manufacturer’s instructions for the mutagenesis of pMUG1-
Myc-PRH to produce pMUG1-Myc-PRH R188AR189A and pMUG1-Myc-PRH 
N187A, and for the mutagenesis of pMUG1-Myc-PRHF32E to produce pMUG1-
Myc-PRHF32E/R188AR189A and pMUG1-Myc-PRHF32E/N187A. The resulting 
mutants were fully sequenced to confirm the sequence change. pcDNA3-Myc-PRH-
HD 130-198 was created by cloning a BamHI-EcoRI fragment encoding the PRH 
homeodomain (amino acids 130-198 followed by an in frame stop) into the  pcDNA3 
vector (Invitrogen). The fragment was generated using PCR and a 5’ primer that 
contains the Myc epitope. The Myc tag is underlined: 5’ primer 
5’CGGGAATCCATGGAACAAAAACTCATCTCAGAAGAGGATCTGTTGCAG
AGGCCTCTGCATAAAAGG 3’, 3’ primer 5’AGAGAATTCCTACTCCTGTTT 
TAGTCTCCTCCA  3’ The eGFP-PRH plasmid was constructed by inserting the 
PRH cDNA from a BlueScipt clone into the EcoRI and KpnI sites of eGFPc1 
(Clontech). 
The pTK-PRH reporter plasmid has been described previously [6]. The pSV-
β-galactosidase control vector (pSV-lacZ) was obtained from Promega. The 
mammalian expression plasmid pCMV2-Flag-TLE1 contains TLE1 coding sequence 
in frame with the Flag epitope [7].  
  
Bacterial Expression Plasmids 
The plasmid pTrcHisA-hPRH expresses recombinant full-length histidine-
tagged and Myc-tagged human PRH7-270 in bacteria and has been described 
previously [2]. pTrcHisA-PRH-hHD expresses a histidine tagged truncated PRH 
construct consisting of the human PRH homeodomain. This construct was generated 
by cloning a PCR fragment carrying the PRH human homeodomain (amino acids 
130-198 followed by an in frame stop) between the XhoI and EcoRI sites of 
pTrcHisA using the primers 5’AGACTCGAGTTGCAGAGGCCTCTGCATAA 
AAGG 3’ and 5’AGAGAATTCCTACTCCTGTTTTAGTCTCCTCCA 3’ (the 
restriction sites are underlined). The expression plasmids pTrcHisA-Myc-PRHF32E, 
pTrcHisA-Myc-PRH R188A,R189A, pTrcHisA-Myc-PRH N187A, pTrcHisA-Myc-
PRHF32E/R188A,R189A and pTrcHisA-Myc-PRHF32E/N187A were created by 
cloning BamHI-EcoRI fragments encoding the mutated human PRH cDNAs from the 
corresponding pMUG1 series of plasmids (described above) into pTrcHisA.  
 
Expression and purification of tagged-PRH proteins  
The His-PRH fusion proteins were expressed in BL21 pLysS cells (Novagen). 
Fusion protein expression was induced with 1mM IPTG. Cells were harvested after 
4h at 37°C, resuspended in lysis buffer (100mM phosphate buffer pH 7.4, 300mM 
NaCl, 10mM imidazole, 5µg/ml DNase, 10µg/ml RNase) and lysed by the addition of 
100µl of lysozyme (1mg/ml) for 20min, followed by 4 bursts of sonication at 60% 
amplitude. After centrifugation for 30min at 18000rpm (Sorval RC-3B rotor) the His-
PRH fusion proteins contained in the supernatant were purified over a Hitrap 
chelating column charged with nickel ions (1ml, Amersham Pharmacia Biotech) 
using an ÄKTA FPLC system and UNICORN 3.10 software. Proteins were eluted 
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with a 250mM imidazole buffer. Aliquots of these proteins were assayed for purity by 
SDS.PAGE followed by staining with Coomassie blue. Proteins were quantified using 
the Bio-RAD phosphoric acid protein assay and stored at -80°C after dialysis into 
PBS containing 20% glycerol. 
 
EMSA 
A double-stranded oligonucleotide carrying a PRH binding site was produced 
by heating the complementary single-stranded oligonucleotides shown below at 90ºC 
for 1 minute and then slow cooling to 20ºC: 
 
5’ GCTTCTGGGAAGCAATTAAAAAATGGCTCGAGCT 3’  
   3’ AGACCCTTCGTTAATTTTTTACCGAGC 5’ 
 
This oligonucleotide (400ng) was labelled with [α32]P dATP using Klenow enzyme at 
30ºC for 30 minutes. Unincorporated [α32]P dATP was then removed using a Micro 
Bio-Spin 6 column (Bio-Rad). The labelled oligonucleotide (100pM) was incubated 
with purified His-tagged proteins in 20mM Tris pH 8.0, 50mM NaCl, 1mM MgCl2, 
1mM dithiothreitol, 80ng/ml poly(dI.dC)(dI.dC), 0.5mg/ml bovine serum albumin, 
and 10% glycerol at 4ºC for 30min. Free and bound DNA was then separated on 6% 
non-denaturing polyacrylamide gels run in 0.5xTBE and quantified using a 
PhosphorImager with Molecular Dynamics ImageQuant software (version 3.3). All 
experiments were repeated three times. 
 
Cell culture and transfection assays   
K562 cells were maintained in DMEM media supplemented with 10% foetal 
calf serum and penicillin/ streptomycin at 37oC in an atmosphere of 5% CO2, 20% O2 
and 80% N2. For transient transfection assays cells were transferred to 0.4cm 
electroporation cuvettes at a density of 1x107 cells in 200µl of media. The cells and 
5µg of the luciferase reporter plasmid and 5µg of the β-galactosidase reporter plasmid 
were mixed by pipetting and electroporated at 250V, 975µF. In repression 
experiments the cells were co-transfected with either pMUG1 vector or the pMUG1-
Myc-PRH series of plasmids as detailed in the Results. Electroporated cells were 
incubated for 24 hours as described above. The cells were then harvested by 
centrifugation and luciferase activity assayed using the Promega Luciferase Assay 
System according to the manufacturer’s instructions. A β-galactosidase assay was 
performed as an internal control for transfection efficiency: 40µl of cell lysate was 
mixed with 900µl of Z buffer (60mM Na2HPO4, 40mM NaH2PO4, 10mM KCl, 1mM 
MgSO4, 50mM β-mercaptoethanol) and 200µl of ONPG (4mg/ml) and incubated at 
37°C for at 1h. The reaction was stopped by adding 200µl of 1M Na2CO3 and the 
absorbance measured at 420nm. After subtraction of the background, the luciferase 
counts were normalised against the β-galactosidase value. 
  
Whole cell extracts and cell fractionation 
Whole cell extracts from 2 x 107 K562 cells were made as follows. The cell 
pellet was collected by centrifugation for 5 min at 1500rpm in a Centurion bench top 
centrifuge. The cell pellet was washed in PBS twice and then resuspended in 400µl 
lysis buffer (150mM NaCl, 50mM Tris pH 7.5, 0.1% SDS, 0.1% NP-40). The cell 
suspension was drawn up and down six times through a 3 X Monojet needle 
(1.1x50mm, 19Gx2”), incubated on ice for 20 min, and then centrifuged at maximum 
speed for 15 min at 4°C in a microcentrifuge.  
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Nuclear and post nuclear extracts were made as follows: 2 x 107 K562 cells 
were centrifuged at 4000rpm (IEC Centra 4B) and the pellet was resuspended in 
400µl (20mM Tris pH7.5, 5mM MgCl2, 1mM DTT containing protease inhibitor 
cocktail (SIGMA)) at 4°C for 10min. 15µl NP40 (10%v/v) was added to the lysate 
and mixed by vortexing. The lysate was centrifuged for 1 min at 13,000rpm in a 
microcentrifuge and the supernatant removed and stored at -80°C as the soluble post-
nuclear fraction. The nuclei in the pellet were resuspended in (50mM Tris pH7.5, 
500mM NaCl, 1% NP40, 0.1% SDS, containing protease inhibitor cocktail (Roche)) 
for 20 min at 4°C and then centrifuged for 1 min at 13,000 rpm in a microcentrifuge. 
The supernatant was removed and stored at -80°C as the soluble nuclear extract.  
 
Phosphatase experiments 
Calf Intestinal Phosphatase (CIP) and CIP buffer was obtained from 
(Fermentas). K562 nuclear extracts prepared from cells expressing Myc-PRH were 
incubated with a cocktail of phosphatase inhibitors in CIP buffer for 30 mins at 4ºC or 
37ºC. (Phosphatase inhibitor cocktail: NaF 50mM, Na3VO4 1mM, 
Naβglycerophosphate 10mM, EDTA 1mM, Na pyrophosphate 5mM). 1 or 2 µl of 
CIP was added to nuclear extracts either containing phosphatase inhibitors or without 
phosphatase inhibitors for 30 mins at 37ºC.  
 
Co-immunopreciptitation assays 
K562 cells (2 X 107) were co-transfected with pCMV2-FLAG-TLE1 and either 
pMUG1-Myc-PRH or one of the pMUG1-Myc-PRH derivatives as described above. 
Whole cell extracts were prepared by resuspending the cell pellet into 150µl of lysis 
buffer (50mM Tris pH8, 100mM NaCl, 20 mM NaF, 10mM KH2PO4, 1mM DTT, 1% 
Triton, 10% glycerol) for 30 min at 4°C. An equivalent volume of binding buffer 
(50mM Tris pH8, 100mM KCl, 0.1mM EDTA, 2mM DTT, 0.2% Nonidet P-40, 0,1% 
BSA, 2.5% glycerol) was added to the lysate before incubation with a monoclonal 
anti-Myc9E10 antibody (Santa Cruz Biotechnology) for 1h at 4 °C under agitation. 
Protein G beads (Sigma) were then washed with the binding buffer and incubated 
with the extracts for a further 2h at 4°C. After this time, the beads were collected by 
centrifugation in an Eppendorf microcentrifuge (13,000 rpm for 1 min), washed three 
times in 1 ml of buffer (50 mM Tris, pH8, 200mM NaCl, 2mM DTT, 0.5% Nonidet 
P-40), and then resuspended in SDS loading buffer. All operations were carried out at 
4°C and in the presence of protease inhibitor cocktail (SIGMA). After SDS.PAGE, 
the proteins were immunoblotted onto Immobilon-P membrane, and tagged TLE1 and 
PRH were detected using an anti-FLAG- antibody (SIGMA) and Myc9E10 antibody 
(Santa Cruz Biotechnology) respectively. 
 
Western Blotting 
Post nuclear and nuclear fractions were collected as described above and 
separated by SDS.PAGE. Immunoblots analyses were performed using appropriate 
antibodies to detect endogenous PRH (mouse polyclonal antibody, [6;26]), Myc-
tagged PRH (mouse anti-Myc9E10 antibody, Santa Cruz Biotechnology), endogenous 
TLE proteins (pan-TLE goat polyclonal, sc13373Santa Cruz), Flag-tagged TLE1 
(rabbit anti-Flag polyclonal antibody, SIGMA), HC8 (mouse monoclonal antibody, 
Affiniti) tubulin, (mouse monoclonal MS-581-P1 NeoMarkers), laminA/C (rabbit 
polyclonal sc-20688 Santa Cruz).  
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Immunofluorescence  
K562 cells were adhered to coverslips coated with poly-lysine. After washing 
in PBS the cells were fixed by incubating the coverslips with 4% parafomaldehyde 
for 30 min. The cells were then rinsed with PBS and incubated with PBSA (3% 
Donkey serum in PBS) for 40min to block non-specific antibody binding. After 
rinsing in PBS, antibody staining was performed for 1h with an optimised dilution for 
each different antibody used either alone or in combination (rabbit anti-Flag 
polyclonal antibody (SIGMA) 1:200 and/or a mouse anti-Myc9E10 antibody (Santa 
Cruz Biotechnology) 1:50). The cells were then rinsed in PBS twice and incubated 
with secondary antibodies for 1 hour at 22°C. PRH and TLE1 were detected with a 
TRITC donkey anti-mouse secondary antibody (Stratec) and an Alexa Fluor 488-
labelled donkey anti-rabbit secondary antibody (Molecular Probes) respectively, both 
at a 1:100 dilution. The coverslips were mounted on slides with DAPI-containing 
mounting medium (Vectashield) and immunostained cells were viewed on a Leica 
DM IRBE confocal microscope. Imaging was performed using Leica Confocal 
Software Version 2.00.  
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RESULTS 
 
PRH increases the retention of TLE proteins within the nucleus 
To determine whether PRH alters the sub-cellular localisation of TLE in 
haematopoietic cells we transfected K562 cells with plasmids expressing pFlag-TLE1 
alone or pFlag-TLE1 together with  GFP or GFP-PRH. We examined the sub-cellular 
localisation of these proteins using immunofluorescent staining and confocal 
microscopy. A TRITC-labelled anti-Flag antibody was used to detect Flag-TLE1, the 
intrinsic fluorescence of the GFP proteins was used to detect GFP and GFP-PRH, and 
DAPI was used to detect DNA. Data from representative transfected cells are shown 
in Figure 1A. When expressed alone Flag-TLE1 (red) is present in the cytoplasm and 
nucleus of K562 cells (Fig.1A middle left panel). However co-expression with GFP-
PRH results in the majority of Flag-TLE1 appearing in the nucleus (Fig. 1A, middle 
panel) whereas co-expression with GFP results in the majority of TLE1 remaining in 
the cytoplasm (Fig. 1A, middle right panel). This experiment was repeated using a 
Myc tagged PRH protein to rule out any effects of the GFP tag on PRH activity. 
Immunofluorescence data from representative transfected cells are shown in Figure 
1B. In the absence of Myc-PRH, Flag-TLE1 (green) is present in the nucleus but is 
predominantly present in the cytoplasm of K562 cells. Co-expression of Myc-PRH 
with Flag-TLE1 results in the majority of TLE1 appearing in the nucleus (Fig. 1A, 
middle right panel) together with Myc-PRH (Fig. 1A, bottom right panel). Taken 
together these data suggest that PRH influences the localisation of TLE proteins in 
the cell. 
To examine whether endogenous TLE proteins are also retained in the nucleus 
by expression of Myc-PRH we first examined the subcellular localisation of TLE 
proteins using immunofluorescent staining and confocal microscopy. A FITC labelled 
pan-TLE polyclonal antibody was used to detect the expression of endogenous TLE 
proteins. However these experiments were not conclusive as expression of Myc-PRH 
in the nucleus hindered detection of the endogenous TLE proteins (weak FITC signal) 
in the cell. Therefore, to address this question we next examined the subcellular 
localisation of endogenous TLE proteins using subcellular fractionation and Western 
blotting. K562 cells or K562 cells expressing Myc-PRH were fractionated into the 
post nuclear fraction (PN) consisting of cytoplasmic and loosely held nuclear proteins 
and nuclear fractions consisting of tightly held nuclear proteins. To compare the 
endogenous TLE protein levels in each subcellular compartment an equal amount of 
protein from each fraction was loaded onto an SDS.PAG and the TLE proteins were 
detected using the pan-TLE antibody. Fractionation and equal loading in each fraction 
was assessed by expression of tubulin in the PN fraction and laminA/C in the nuclear 
fraction. Figure 1C shows that endogenous TLE proteins are predominantly localised 
to the PN fraction although a faint band is present in the nuclear fraction (compare 
lanes 1 and 2). In contrast, in the presence of Myc-PRH endogenous TLE is strongly 
present in the nuclear fraction (Fig. 1C compare lanes 3 and 4). The blot was stripped 
and reprobed with the Myc-antibody to detect the Myc-PRH. Myc-PRH is present in 
both the PN and nuclear fractions (Fig. 1C, lanes 3 and 4 lower panel). We conclude 
that PRH increases the nuclear retention of TLE proteins. Our previous 
immunofluoresence experiments with Myc-PRH have shown that PRH is present in 
both the nucleus and the cytoplasm [7]. This is in agreement with the fractionation 
experiments presented in Figure 1. However PRH localisation in the presence of TLE 
appears strongly nuclear in the immunofluorescence experiments shown above. This 
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suggests that co-expression of PRH with TLE has an influence on the localisation of 
PRH and vice versa.  
TLE runs as a doublet on an SDS.PAG due to phosphorylation [49].  The 
upper TLE band in Fig. 1C (lane 4) very likely corresponds to hyperphosphorylated 
TLE and expression of PRH brings about an increase in the intensity of this band 
suggesting that PRH induces TLE phosphorylation (Fig. 1C, compare lane 1 with lane 
4). To establish that the TLE proteins of retarded mobility correspond to TLE 
phosphoproteins induced by PRH expression we incubated K562 nuclear extracts 
transfected with Myc-PRH with Calf Intestinal Phosphatase (CIP).  There is a 
predominance of the TLE band of retarded mobility (Fig. 1D, lanes 1 and 2) after 
incubation at 4ºC or 37ºC in the presence of a cocktail of phosphatase inhibitors. 
Incubation of nuclear extracts with CIP in the absence of phosphatase inhibitors 
results in a decrease in the intensity of this upper band and an increase in intensity of 
the lower TLE band (lanes 3 and 4). In contrast, incubation of the extracts with CIP in 
the presence of phosphatase inhibitors does not lead to a change in the TLE band 
(lane 5). These data show that the TLE band of reduced mobility observed in the 
presence of Myc-PRH corresponds to phosphorylated TLE.  
 
 
Mutations in the PRH homeodomain block nuclear relocalisation of TLE  
To investigate whether the DNA binding and nuclear localisation activities of 
PRH are required for the relocalisation of TLE proteins we designed two mutations in 
the Myc-PRH protein: PRH N187A, and PRH R188A,R189A. These mutations lie in 
the homeodomain of the PRH protein and are shown in Figure 2A. The N187A 
mutation is predicted to significantly reduce the DNA binding activity of PRH since 
we have shown previously that mutation of asparagine to alanine at the equivalent 
position in the highly conserved avian PRH homeodomain prevents DNA binding [6]. 
The R188A,R189A  double mutation is predicted to prevent the nuclear localisation 
of PRH as mutation of these arginine residues to alanine has been reported to block 
the nuclear localisation of PRH in NIH3T3 cells [12]. To create these mutations we 
performed site-directed mutagenesis of PRH in the expression plasmid pMUG1-Myc-
PRH (as described in the Experimental).  To check that the mutated Myc-tagged PRH 
proteins are expressed at similar levels K562 cells were transfected with plasmids 
expressing Myc-PRH or each of the mutant Myc-PRH proteins and cell extracts were 
produced. Western Blotting with the anti-Myc antibody and tubulin antibodies shows 
that these proteins are expressed at equivalent levels in K562 cells (Fig. 2B). 
To determine whether PRH proteins that carry these mutations can alter the 
retention of TLE proteins, K562 cells, or K562 cells expressing Myc-PRH or the 
mutated proteins were fractionated into nuclear and PN extracts. Equal amounts of 
total protein from each fraction were loaded onto an SDS.PAG and Western blotted 
with a pan-TLE antibody (Fig. 3A, upper panel) or an anti-Myc antibody (Fig. 3A, 
lower panel). The blots were stripped and reprobed for lamin A/C and tubulin to 
examine fractionation quality and loading as before. As expected, wild type PRH is 
able to alter the distribution of  TLE proteins in each fraction and to induce TLE 
hyperphosphorylation (Fig. 3A, compare lanes 1 and 5 with lanes 2 and 6).  However 
both mutant PRH proteins are unable to influence the distribution of endogenous TLE 
(Fig. 3A, upper panel, lanes 7 and 8). Although these data suggest that both the DNA 
binding activity of PRH and the nuclear localisation of PRH are required in order to 
retain nuclear TLE proteins, it is clear that the nuclear localisation mutant Myc-PRH 
R188A,R189A is present in both the PN and nuclear extracts (Fig. 3A, lower panel).  
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To further examine the localisation of the mutant PRH proteins we used 
immunofluorescence microscopy. Figure 3B shows high magnification pictures of 
K562 cells stained with DAPI to visualise the DNA (blue) and with TRITC (red) to 
visualise the PRH proteins. When the DAPI stain and the TRITC stain are merged the 
cells appear pink demonstrating that wild type PRH and the mutant PRH proteins are 
present in the nucleus of K562 cells. These results demonstrate that in these cells 
PRH N187A and PRH R188A,R189A are able to localise in the nucleus like wild 
type PRH. We conclude that in K562 cells PRH R188A,R189A is not defective in 
nuclear localisation. 
 
PRH R188A,R189A has a defect in DNA binding 
We next investigated the DNA binding properties of the mutated proteins. The 
mutated PRH cDNAs present in the mammalian expression constructs were 
transferred to the pTrc-HisA bacterial expression vector (see Experimental). The 
resulting constructs inducibly express Histidine-tagged mutated PRH proteins in 
bacterial cells. Bacterial extracts expressing the mutated PRH proteins or the wild 
type protein were used to partially purify Histidine tagged PRH proteins over a 
Nickel charged affinity column and these partially purified proteins were used in 
EMSA with a labelled PRH binding site as described previously [2;34]. Figure 3C 
shows that full length His-PRH is able to bind to DNA in the EMSA and form two 
retarded DNA-PRH complexes. In contrast, neither His-PRH N187A nor His-PRH 
R188A,R189A form PRH-DNA complexes.   
In summary, we have demonstrated that both PRH N187A and PRH 
R188A,R189A can localise to the nucleus and that they are both defective in DNA 
binding and influencing the nuclear retention of TLE proteins. Since both mutations 
in the homeodomain block DNA binding and the nuclear retention of TLE proteins 
but do not appear to significantly affect the nuclear retention of PRH, we conclude 
that DNA binding by PRH is necessary for the retention of TLE within the nucleus.  
 
Mutation of the PRH Eh-1 motif blocks nuclear retention of TLE  
To investigate whether the PRH-TLE interaction is required for the nuclear 
retention of TLE proteins we examined the sub cellular distribution of TLE proteins 
in the presence of Myc-PRH F32E (see Fig. 2). A plasmid expressing Myc-PRH 
F32E was produced in our earlier study [7]. The PRH F32E mutation was designed to 
inhibit the binding of PRH to TLE1. This mutation lies in the N-terminal Eh-1 motif 
in PRH and our previous studies have shown that this mutation eliminates the 
interaction between TLE1 and the PRH N-terminal domain [7]. K562 cells, or cells 
expressing Myc-PRH or Myc-PRH F32E were fractionated and Western blotted as 
described above. Figure 4A (upper panel) shows that PRH F32E is unable to alter the 
nuclear retention of endogenous TLE proteins (lanes 3 and 6). These fractionation 
experiments also demonstrate that the mutant PRH F32E protein is not altered in its 
ability to be retained in the nucleus compared to wild type PRH and is expressed at a 
similar level to wild type PRH (Fig. 4A, lower panel). The mutant protein shows a 
slightly retarded mobility compared to wild type PRH (Fig. 4A, lower panel). The 
changed mobility of the protein is also apparent in a fusion protein consisting of GST 
fused to the PRH N-terminal domain carrying the F32E mutation [7]. The reason for 
this apparent change in mobility is not known at present. We confirmed that the 
nuclear localisation of the PRH F32E is not altered compared to wild type PRH, using 
immunostaining experiments and confocal microscopy (Figure 4B, middle panel). 
Thus the F32E mutation in the Eh-1 domain of PRH does not appear to alter nuclear 
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localisation of PRH but does block the influence of PRH on the retention of TLE 
proteins.  
To check that the DNA binding properties of PRH are not altered by the F32E 
mutation in the Eh-1 domain we transferred the mutated PRH cDNA present in the 
mammalian expression constructs to a bacterial expression vector downstream of a 
His-tag. The His-tagged proteins were then partially purified and used in EMSA in 
parallel with the EMSA carried out previously for the wild type PRH protein and the 
PRH proteins carrying mutations in the homeodomain. Figure 3C shows that PRH 
F32E is able to bind DNA and forms the same PRH-DNA complexes as wild type 
PRH (compare lanes 3 and 12). Therefore the PRH F32E mutation does not 
significantly alter the DNA binding properties of PRH. 
 The F32E mutation blocks the binding of the isolated PRH N-terminal domain 
to TLE in pull down experiments. To confirm that the F32E mutation inhibits the 
binding of PRH to TLE in the context of full length PRH protein in vivo, we carried 
out co-immunoprecipitation experiments with Myc-tagged PRH and Flag-tagged 
TLE1. Cell extracts were made from K562 cells expressing Myc-PRH and Flag-TLE1 
or each of the mutant Myc-PRH proteins and Flag-TLE1 and immunoprecipitated 
with an anti-Myc antibody bound to Protein G beads. After extensive washing the 
proteins were loaded onto an SDS.PAG and Western blotted with the Myc antibody 
to detect Myc-PRH and with a Flag antibody to detect Flag-TLE1. Figure 4C (upper 
panel) shows that the Myc-tagged PRH proteins are all immunoprecipitated by the 
Myc antibody to approximately the same extent. PRH and the PRH N187A and PRH 
R188A,R189A mutants all co-immunoprecipitate Flag-tagged TLE, whereas PRH 
F32E fails to co-immunoprecipitate TLE (lower panel). These data demonstrate that 
the F32E mutation in the PRH Eh-1 domain prevents the interaction of PRH and TLE 
in cells. In this experiment the PRH N187A appears to immunoprecipitate much more 
TLE than the corresponding wild type PRH protein which may reflect an increased 
binding affinity between PRH N187A and TLE proteins.  
 
Repression by PRH requires retention of TLE proteins in the nuclear fraction.  
In order to study the transcription repression properties of these mutated PRH 
proteins a reporter plasmid carrying the luciferase gene under the control of the TK 
promoter and 5 PRH binding sites was transiently transfected into K562 cells with 
vectors expressing PRH or the PRH mutants. In addition, all cells were co-transfected 
with a plasmid expressing β-galactosidase to act as a control for transient transfection 
efficiency. Figure 5A show that whilst PRH represses reporter activity to around 30% 
of the unrepressed level, the DNA binding deficient mutants PRH N187A and PRH 
R188A,R189A show little or no repression activity. In this assay PRH F32E is a very 
poor repressor and has no more repression activity than the DNA binding defective 
protein PRH N187A (Fig. 5A, column 6). PRH is able to repress transcription by 
several mechanisms including binding to the TATA box and we have shown 
previously that at high expression levels PRH F32E has some ability to repress 
transcription, presumably via binding to the TATA box or because of residual binding 
to TLE. Here we have directly compared the repression activity of PRH F32E with 
that of wild type PRH and Western blotting confirms that in this assay the proteins 
are expressed at equivalent levels in the transfected cells (Fig. 2B). We have 
demonstrated that PRH F32E does not influence the retention of  TLE proteins in the 
nucleus and that this protein can bind to DNA like wild type PRH. We conclude that 
the direct interaction between PRH and TLE is essential for the enhanced nuclear 
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retention of TLE proteins brought about by PRH and plays an important role in 
transcriptional repression by PRH.  
 
 
PRH N187A is trans-dominant over PRH  
The data presented above demonstrate that PRH N187A, PRH R188A,R189A 
and PRH F32E are all defective in repression. In order to further dissect the 
mechanisms whereby PRH represses transcription, we next examined whether any of 
these mutant PRH proteins would have a trans-dominant negative activity over 
transcriptional repression by wild type PRH. The pTK-PRH reporter plasmid 
described above was transfected into K562 cells with plasmids expressing wild type 
PRH and increasing amounts of each of the plasmids expressing mutant PRH 
proteins. As before, all cells were transfected with a plasmid expressing β-
galactosidase to control for transfection efficiency. Figure 5B shows that as expected, 
PRH represses transcription to about 40% of unrepressed promoter activity (lane 2). 
Increasing amounts of PRH N187A (lanes 3-5), PRH F32E (lanes 9-11) or PRH 
R188A,R189A (lanes 15-17) do not result in transcriptional repression (as shown 
previously in Fig. 5A). However, co-expression of PRH with increasing amounts of 
PRH N187A results in a significant decrease in repression by PRH (lanes 6-8) and at 
a 2:1 ratio of PRH N187:PRH there is almost a complete loss of repression. In 
contrast, co-expression of PRH with increasing amounts of PRH F32E (lanes 12-14) 
or PRH R188A,R189A (lanes 18-20) does not alter the repression activity of PRH. 
Thus, these data demonstrate that PRH N187A has a trans-dominant negative activity 
over wild-type PRH for transcriptional repression. 
To investigate the mechanism of this trans-dominant inhibition of PRH 
repression activity we used site-directed mutagenesis to make two PRH expression 
plasmids that carry either a combination of the F32E and N187A mutations or the 
F32E and R188A,R189A mutations. K562 cells were transfected with the reporter 
plasmid, the PRH expression vector and increasing amounts of plasmids expressing 
these double mutants. Western blotting confirms that the double mutants are 
expressed at equivalent levels to wild type PRH (Fig. 5C). Figure 5D shows that PRH 
represses transcription to about 30% of unrepressed promoter activity (lane 2) and 
that increasing amounts of PRH F32E,N187A (lanes 3-5), or PRH 
F32E,R188A,R189A (lanes 9-11) do not result in transcriptional repression. Co-
expression of PRH with increasing amounts of PRH F32E,N187A (lanes 6-8) or PRH 
F32E,R188A,R189A (12-14) does not result in a decrease in repression activity. 
Since PRH N187A has trans-dominant negative activity but PRH F32E,N187A does 
not, we infer that titration of TLE is essential for the trans-dominant negative activity 
of PRH N187A.  
We have previously shown that Myc-PRH expression is cytoplasmic and 
diffuse nuclear [7] and that the accumulation of this protein in nuclear foci is apparent 
at lower levels of expression [2]. We have also shown that co-expression of PRH with 
Flag-TLE1 protein results in their co-localisation.  Both proteins show diffuse nuclear 
staining but in addition there is  co-localisation in sub-nuclear foci [7]. To determine 
whether the trans-dominant negative protein PRH N187A is able to sequester TLE 
proteins away from wild type PRH and into a particular sub-nuclear compartment we 
expressed Flag-TLE1 protein in K562 cells. The Flag-TLE protein shows a diffuse 
nuclear staining pattern (Figure 1A.) We also expressed each of the Myc-PRH 
proteins in K562 cells (Figure 3B and 4B) and these proteins also showed diffuse 
nuclear staining. Interestingly, the co-expression of Myc-PRH N187A and Flag-TLE1 
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shows strong co-localisation of the two proteins in sub-nuclear foci (Figure 5E) in 
immunofluorescent staining experiments (large yellow dots). In contrast, the 
coexpression of TRITC labelled Myc-PRH (wild type) or Myc-PRH F32E with Flag-
TLE1 results in co-localisation in the nucleus in a predominantly diffuse nuclear 
staining pattern (Figure 5E). We conclude that the sub-nuclear localisation of PRH 
N187A and TLE1 are altered when the proteins are co-expressed. Thus, the 
interaction of PRH N187A with TLE results in the sequestration of TLE in a sub-
nuclear compartment that is not the same as the sub-nuclear compartment occupied 
by wild type PRH and TLE1. We infer that the inability of PRH to bind to DNA 
prevents PRH N187A from taking TLE1 to the DNA/chromatin or alternatively 
prevents TLE1 from taking PRHN187A to the DNA/chromatin. In any event we 
conclude that sequestration of TLE proteins to an altered sub-nuclear localisation is 
involved in the trans-dominant negative activity of this protein. 
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 DISCUSSION 
PRH is a transcriptional repressor protein that plays important roles in the 
regulation of several cellular processes including haematopoiesis. PRH is present in 
both the cytoplasm and nucleus of haematopoietic cells from myeloid lineages 
[7;27;31]. Aberrant expression of PRH or loss of nuclear localisation of PRH 
contributes to leukaemia [31]. K562 cells are blast cells that can spontaneously 
differentiate along myeloid and erythroid lineages. In the main these cells contain a 
very large nucleus and relatively little cytoplasm. Immunofluorescent staining of 
PRH and TLE proteins in these cells has shown that PRH and TLE can be present in 
both the nucleus and the cytoplasm [7]. We have used biochemical fractionation to 
examine the nuclear retention of TLE proteins. We have shown that endogenous 
nuclear TLE proteins are not tightly bound in the nuclei of K562 cells and fractionate 
into the post-nuclear fraction. However, in the presence of exogenous PRH, 
endogenous TLE proteins become strongly retained in the nuclear fraction. In other 
cell types the Hes1 and Runx-1 repressor proteins have been shown to bind to TLE 
and increase the nuclear retention of TLE by increasing the association of TLE with 
chromatin [49]. Further experiments are required to establish whether the mechanism 
of nuclear retention of TLE in the presence of PRH is similar to that effected by Hes1 
and involves chromatin association of TLE proteins or other sub-nuclear 
compartments such as the nuclear matrix.  
The mutation of asparagine to alanine (N187A) in the DNA recognition helix 
of the PRH homeodomain and mutation of adjacent arginine residues 
(R188A,R189A) results in proteins that are unable to bind to DNA. These mutants are 
both unable to influence the nuclear retention of TLE proteins although they are able 
to bind to TLE. In fractionation studies both PRH N187A and PRH R188A,R189A 
show both post-nuclear and nuclear distribution. PRH N187A acts as a trans-
dominant negative protein in repression assays with wild type PRH. In contrast, PRH 
R188A,R189A does not act as a trans-dominant negative. Here we have shown that 
PRH N187A and TLE co-localise in sub-nuclear foci whereas PRH R188A,R189A 
and TLE do not co-localise in these foci. Presumably this difference accounts for the 
trans-dominant repression activity of PRH N187A. However the difference in the 
ability of these proteins to have trans-dominant activity over wild type PRH may be 
because PRH N187A has a higher affinity for TLE or because the PRH 
R188A,R189A has a subtle defect in nuclear retention. It is also possible that the 
higher affinity of PRH N187A for TLE and/or the subtle defect of PRH 
R188A,R189A in nuclear retention  are responsible for the difference in sub-nuclear 
localisation. Finally we cannot rule out the possibility that sequestration of TLE is not 
wholly responsible for the trans-dominant negative activity of PRH N187A. PRH is 
known to form oligomers and it may be that PRH N187A but not the PRH 
R188A,R189A mutant, is able to form hetero-oligomers with wild type PRH and 
thereby block repression. Interestingly, it is clear that in complete contrast to 
previous reports, PRH R188A,R189A is able to enter the nucleus of K562 cells 
suggesting that this mutation does not strongly affect the nuclear localisation of PRH 
in these cells although this mutation does inhibit the nuclear localisation of PRH in 
NIH3T3 cells [12]. One reason for this discrepancy could be that K562 cell specific 
proteins might aid the nuclear import of this mutant.  
As might be expected, a mutation in the Eh1 motif (F32E) located within the 
N-terminal domain of PRH reduces binding to TLE and blocks nuclear retention of 
TLE. Thus the retention of TLE proteins within the nucleus requires two properties of 
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the PRH protein: a direct protein-protein interaction between PRH and TLE and DNA 
binding by PRH. Neither DNA binding alone, nor TLE binding alone by PRH is 
sufficient for nuclear retention of TLE or in fact for transcriptional repression by 
PRH. Presumably the nuclear retention of TLE proteins is necessary for 
transcriptional repression by PRH. We have reported previously that although PRH 
F32E is defective in binding to TLE and defective in repression compared to wild-
type PRH, it retains some repression activity when expressed at high levels. We 
suggest that this is because the mutant is not completely unable to bind TLE and 
retains weak TLE binding activity which may become apparent at very high 
expression levels.  
Since a defect in binding TLE blocks repression as effectively as a defect in 
DNA binding, we conclude that most of the PRH-dependent repression observed at 
the pTK-PRH promoter is TLE-dependent. However it is possible that mutation of the 
Eh-1 domain might also affect the conformation of the PRH protein and hence also 
decrease the interaction of PRH with other PRH-interacting proteins. The trans-
dominant negative activity of the DNA binding mutant PRH N187A together with the 
loss of this trans-dominant negative activity in the PRH F32E,N187A double mutant 
(cannot bind to DNA and TLE) reinforces the idea that transcriptional repression is 
very sensitive to the availability of TLE. PRH N187A may prove to be a useful tool 
for understanding the direct and indirect transcriptional activities of PRH. Clearly the 
ability of PRH N187A to act as a trans-dominant negative for PRH repression activity 
occurs through a very different mechanism from that inferred for the trans-dominant 
negative activity of a Nup-Hex/PRH fusion protein identified recently in a patient 
with Acute Myeloid Leukaemia. In the Nup-Hex/PRH fusion protein, the N-terminus 
of the Nucleoporin protein Nup98 is fused in frame with the homeodomain and C-
terminus of PRH. In this case the N-terminus (TLE binding region) of PRH is absent 
in the fusion protein and it is thought that the trans-dominant negative function of 
Nup-Hex/PRH derives from the ability of the fusion protein to compete with PRH for 
PRH binding sites [32]. The experiments outlined above demonstrate that there is 
more than one way to block PRH repression activity and suggest that AML patients 
might harbour a variety of PRH mutations. 
We have shown here that PRH directly affects nuclear retention of TLE and 
presumably as a consequence, availability of TLE in discrete sub-nuclear domains. 
Thus it is very likely that TLE-dependent genes may be equally sensitive to PRH 
levels. Further work is required to determine whether alterations in PRH expression 
impact on the plethora of TLE-repressed genes that do not appear to contain binding 
sites for PRH. Our studies have shown that PRH can influence the amount of 
available TLE proteins in the nucleus. However it is not known whether binding of 
TLE to PRH results in PRH sequestering TLE away from other transcription factors 
in the nucleus or whether PRH simply increases the amount of free TLE proteins in 
the nucleus. The Wnt signalling pathway functions in haematopoietic progenitors to 
promote self renewal [52]. TLE proteins are important antagonists for Wnt signalling 
[53;54]. The Notch signalling pathway also functions in haematopoietic progenitors 
to inhibit differentiation along myeloid lineages and thereby increase the amount of 
undifferentiated progenitors [55;56]. TLE proteins mediate the Notch signalling 
pathway and thereby promote the inhibition of differentiation [55;56]. Thus an 
increase in available TLE in the nucleus might be expected to inhibit self renewal and 
decrease differentiation. Interestingly PRH functions as an inhibitor of cell 
proliferation in early haematopoietic progenitors and in differentiated myeloid cells. 
Although the effect of PRH on cell proliferation has been shown to be through the 
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regulatory effect of PRH on the translation factor eIF4E [12], the anti-proliferative 
effects of PRH could also be a consequence of PRH altering the amount of available 
nuclear TLE.  
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FIGURE LEGENDS 
Figure 1  PRH alters the distribution of TLE proteins in the cell 
(A) K562 cells were transiently transfected with vectors expressing Flag-TLE1, Flag-
TLE1 and GFP-PRH or Flag-TLE1 and GFP and then adhered to polylysine coated 
coverslips. DNA was stained with DAPI (blue). Flag-TLE1 was visualised using an 
anti-Flag antibody and a TRITC-labelled secondary antibody (red). GFP-PRH and 
GFP were visualised directly (green). The cells were viewed using a Leica DM IRBE 
confocal microscope. (B) K562 cells were transiently transfected with vectors 
expressing Flag-TLE1 or Flag-TLE1 and Myc-PRH and then adhered to polylysine 
coated coverslips. DNA was stained with DAPI (blue). Flag-TLE1 was visualised 
using an anti-Flag antibody and a FITC-labelled secondary antibody (green). Myc-
PRH was visualised using the Myc9E10 antibody and a TRITC-labelled secondary 
antibody (red). The cells were viewed using confocal microscopy as above. (C) 
Untransfected K562 cells and cells transiently transfected with a vector expressing 
Myc-PRH were fractionated into post nuclear (PN) and nuclear (Nuc) extracts. The 
proteins were then separated by SDS.PAGE and Western blotted for endogenous TLE 
proteins (Endog. TLE) using a pan-TLE antibody (top panel), lamin A/C using a 
rabbit polyclonal anti-lamin antibody (second panel) tubulin using a mouse 
monoclonal anti-tubulin antibody (third panel) and Myc-PRH using the Myc9E10 
antibody (bottom panel). (D) K562 nuclear extracts from cells expressing Myc-PRH 
were incubated with a cocktail of phosphatase inhibitors in CIP buffer for 30 mins at 
4ºC (lane 1) or 37º C (lane 2). 1µl (lane 3) or 2 µl (lane 4) of CIP was added to 
nuclear extracts without phosphatase inhibitors for 30 mins at 37ºC. 2µl CIP (lane 5) 
was added to nuclear extracts containing phosphatase inhibitors for 30 mins at 37ºC. 
 
Figure 2  PRH mutants used in this study. 
(A) A schematic representation of the PRH protein and the PRH mutants used in this 
study. The Myc tag is represented by the filled box. The proline-rich domain and 
homeodomain (HD) are indicated. (B) Whole cell extracts were prepared from 
untransfected K562 cells (1) and cells transiently transfected with vectors expressing 
Myc-PRH (2), Myc-PRH R188A,R189A (3), Myc-PRH N187A (4) or Myc-PRH 
F32E (5). The proteins were then separated by SDS.PAGE and Western blotted for 
PRH using the Myc9E10 antibody and a mouse monoclonal anit-tubulin antibody as a 
control for protein loading. 
 
Figure 3  Mutations in the PRH homeodomain block nuclear retention of TLE   
(A) Untransfected K562 cells and cells transiently transfected with vectors expressing 
Myc-PRH, Myc-PRH N187A, or Myc-PRH R188A,R189A were fractionated into 
post nuclear and nuclear extracts. The proteins were then separated by SDS.PAGE 
and Western blotted for endogenous TLE (TLE) (top panel), lamin A/C (second 
panel), tubulin (third panel), or Myc-PRH proteins (bottom panel) as described in Fig. 
1C. (B) K562 cells growing on coverslips were transiently transfected with vectors 
expressing Myc-PRH, Myc-PRH N187A, or Myc-PRH R188A,R189A. DNA was 
stained with DAPI (blue) and Myc-PRH was visualised using the Myc9E10 antibody 
and a TRITC-labelled secondary antibody (red). The cells were viewed using a Leica 
DM IRBE confocal microscope. (C) A labelled oligonucleotide carrying a PRH 
binding site was incubated with increasing concentrations (125, 250 and 500nM) of 
histidine-tagged PRH (lanes 1-3), or histidine-tagged PRH R188A,R189A (lanes 4-6), 
PRH N187A (lanes 7-9), and PRH F32E (lanes 10-12) under the conditions described 
in the text. Free and bound DNA was then resolved on a 6% polyacrylamide gel and 
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visualised using a PhosphorImager. Two retarded complexes (C1 and C2) are formed 
when PRH binds to the DNA.  
 
Figure 4  Mutation of the PRH Eh-1 motif blocks the nuclear retention of TLE.  
(A) Untransfected K562 cells and cells transiently transfected with vectors expressing 
Myc-PRH, or Myc-PRH F32E were fractionated into post nuclear and nuclear 
extracts. The proteins were then separated by SDS.PAGE and Western blotted for 
endogenous TLE (TLE) (top panel), Myc-PRH proteins (bottom panel), lamin A/C 
(second panel ) or tubulin (third panel) as described in Fig. 1C. (B) K562 cells 
growing on coverslips were transiently transfected with a vector expressing Myc-
PRH F32E. DNA was stained with DAPI (blue) and Myc-PRH F32E (red) was 
visualised exactly as described in Fig. 3B. (C) Whole cell extracts were prepared 
from K562 cells transiently co-transfected with a vector expressing Flag-TLE1 and 
vectors expressing Myc-PRH (1), Myc-PRH R188A,R189A (2), Myc-PRH N187A 
(3) or Myc-PRH F32E (4). The Myc-tagged proteins were then immunoprecipitated 
using the Myc9E10 antibody. The immunoprecipitated proteins were separated by 
SDS.PAGE and western blotted for PRH using the Myc9E10 antibody (top panel) 
and co-immunoprecipitated TLE using the Flag antibody (lower panel). 
 
Figure 5  PRH N187A is trans-dominant over PRH in transcription repression assays.  
The graphs shows the relative promoter activity found in K562 cell extracts 24 h after 
transient co-transfection with a reporter plasmid containing the luciferase gene under 
the control of the TK promoter and 5 PRH binding sites (pTK-PRH), a β-
galactosidase expression plasmid (pSV-lacZ) and PRH expression vectors. Relative 
promoter activity is the luciferase activity normalized with respect to transfection 
efficiency using the co-transfected β-galactosidase plasmid. Each transfection was 
performed a minimum of three times and the values shown are the means and 
standard deviation. (A) K562 cells were transfected with 5µg pTK-PRH alone (1), or 
pTK-PRH and 1µg of an empty expression vector (2), or pTK-PRH and 1µg pMUG1-
PRH (3), pMUG1-PRH R188A,R189A (4), pMUG1-PRH N187A (5), pMUG1-PRH 
F32E (5). (B) K562 cells were transfected with 5µg of pTK-PRH alone (1), pTK-
PRH and 1µg of pMUG1-PRH (2), or pTK-PRH and increasing amounts (0.5, 1 and 2 
µg) of the expressor plasmids indicated either with (filled bars) or without (empty 
bars) 1µg of co-transfected pMUG1-PRH. (C) Whole cell extracts were prepared 
from untransfected K562 cells (1) and cells transiently transfected with vectors 
expressing Myc-PRH F32E,N187A (2), Myc-PRH F32E,R188A,R189A (3) or Myc-
PRH (4). The proteins were then separated by SDS.PAGE and Western blotted for 
PRH using the Myc9E10 antibody. The membrane was stripped and reprobed with 
tubulin antibody as a control for protein loading. (D) The experiment described in 
part B was repeated using vectors expressing the PRH double mutants PRH 
F32E,N187A and PRH F32E,R188A,R189A. (E) K562 cells were transiently 
transfected with vectors expressing Flag-TLE1 and Myc-PRH or Myc tagged PRH 
mutant proteins and then adhered to polylysine coated coverslips. DNA was stained 
with DAPI (blue). Flag-TLE1 was visualised using an anti-Flag antibody and a FITC-
labelled secondary antibody (green). Myc-PRH was visualised using the Myc9E10 
antibody and a TRITC-labelled secondary antibody (red). The cells were viewed 
using confocal microscopy as above. Co-localised proteins produce yellow colour.    
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